Skip to main content

Advertisement

Log in

IL-10 promoter polymorphism associated with decreased risk of aGvHD after stem cell transplantation: a meta-analysis

  • Original Article
  • Published:
International Journal of Hematology Aims and scope Submit manuscript

Abstract

The bulk of evidences indicates that variations in the coding for cytokines or the regulation of their expression may play a role in acute graft-versus-host disease (aGvHD) following allogeneic hematopoietic stem cell transplantation (HSCT). It is unclear whether IL-10 promoter polymorphism is associated with the occurrence of aGvHD in allogeneic HSCT. A systematic search was performed in PubMed and Embase databases and 10 studies were identified for inclusion. Data were extracted and pooled ORs together with 95 % CIs were calculated. The pooled result indicated that −592A allele in recipient was significantly associated with reduced risk of moderate aGvHD in HSCT [OR = 0.41 (0.21, 0.79), P = 0.008, I 2 = 25 %]. The same pattern was also obtained from the −819T allele in recipient [OR = 0.38 (0.18, 0.79), P = 0.01, I 2 = 41 %]. Furthermore, we found a significant positive correlation between the −592AA homozygote and lower risk of severe aGvHD in HSCT [OR = 0.54 (0.34, 0.86), P = 0.01, I 2 = 29 %]. The similar result was gained from the −1082A allele in recipient and decreased risk of severe aGvHD [OR = 0.71 (0.52, 0.98), P = 0.04, I 2 = 19 %]. However, there was no significant association between −592A, −819T, or −1082A allele in donor and risk of aGvHD. This meta-analysis suggests that the IL-10 A allele or AA homozygote at −592, T allele at −819 and the A allele at −1082 are associated with reduced risk of aGvHD in allogeneic HSCT.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Kaitin K. Graft-versus-host disease. N Engl J Med. 1991;325:357–8.

    PubMed  CAS  Google Scholar 

  2. Beatty P, Clift R, Mickelson E, Nisperos B, Flournoy N, Martin P, Sanders J, Stewart P, Buckner C, Storb R. Marrow transplantation from related donors other than HLA-identical siblings. N Engl J Med. 1985;313:765–71.

    Article  PubMed  CAS  Google Scholar 

  3. Flomenberg N, Baxter-Lowe L, Confer D, Fernandez-Vina M, Filipovich A, Horowitz M, Hurley C, Kollman C, Anasetti C, Noreen H. Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome. Blood. 1923;2004:104.

    Google Scholar 

  4. Petersdorf E. HLA matching in allogeneic stem cell transplantation. Curr Opin Hematol. 2004;11:386.

    Article  PubMed  CAS  Google Scholar 

  5. Perreault C, Decary F, Brochu S, Gyger M, Belanger R, Roy D. Minor histocompatibility antigens. Blood. 1990;76:1269.

    PubMed  CAS  Google Scholar 

  6. Krenger W, Hill G, Ferrara J. Cytokine Cascades in Acute Graft-Versus-Host Disease 1. Transplantation. 1997;64:553.

    Article  PubMed  CAS  Google Scholar 

  7. Bidwell J, Keen L, Gallagher G, Kimberly R, Huizinga T, McDermott M, Oksenberg J, McNicholl J, Pociot F, Hardt C. Cytokine gene polymorphism in human disease: on-line databases. Genes Immun. 1999;1:3–19.

    Article  PubMed  CAS  Google Scholar 

  8. Fiorentino D, Zlotnik A, Mosmann T, Howard M, O’garra A. IL-10 inhibits cytokine production by activated macrophages. J Immunol. 1991;147:3815.

    PubMed  CAS  Google Scholar 

  9. Ding L, Linsley P, Huang L, Germain R, Shevach E. IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression. J Immunol. 1993;151:1224.

    PubMed  CAS  Google Scholar 

  10. Groux H, Bigler M, De Vries J, Roncarolo M. Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells. J Exp Med. 1996;184:19.

    Article  PubMed  CAS  Google Scholar 

  11. Tseng L, Storer B, Petersdorf E, Lin M, Chien J, Grogan B, Malkki M, Chen P, Zhao L, Martin P. IL10 and IL10 receptor gene variation and outcomes after unrelated and related hematopoietic cell transplantation. Transplantation. 2009;87:704.

    Article  PubMed  CAS  Google Scholar 

  12. Lin M, Storer B, Martin P, Tseng L, Grogan B, Chen P, Zhao L, Hansen J. Genetic variation in the IL-10 pathway modulates severity of acute graft-versus-host disease following hematopoietic cell transplantation: synergism between IL-10 genotype of patient and IL-10 receptor beta genotype of donor. Blood. 2005;106:3995.

    Article  PubMed  CAS  Google Scholar 

  13. Sivula J, Turpeinen H, Volin L, Partanen J. Association of IL-10 and IL-10 R¦Â gene polymorphisms with graft-versus-host disease after haematopoietic stem cell transplantation from an HLA-identical sibling donor. BMC immunology. 2009;10:24.

    Article  PubMed  Google Scholar 

  14. Lin M, Storer B, Martin P, Tseng L, Gooley T, Chen P, Hansen J. Relation of an interleukin-10 promoter polymorphism to graft-versus-host disease and survival after hematopoietic-cell transplantation. New Engl J Med. 2003;349:2201.

    Article  PubMed  CAS  Google Scholar 

  15. Bertinetto F, Dall’Omo A, Mazzola G, Rendine S, Berrino M, Bertola L, Magistroni P, Caropreso P, Falda M, Locatelli F. Role of non-HLA genetic polymorphisms in graft-versus-host disease after haematopoietic stem cell transplantation. Int J Immunogenet. 2006;33:375–84.

    Article  PubMed  CAS  Google Scholar 

  16. Socie G, Loiseau P, Tamouza R, Janin A, Busson M, Gluckman E, Charron D. Both genetic and clinical factors predict the development of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Transplantation. 2001;72:699–706.

    Article  PubMed  CAS  Google Scholar 

  17. Cavet J, Middleton P, Segall M, Noreen H, Davies S, Dickinson A. Recipient tumor necrosis factor-alpha and interleukin-10 gene polymorphisms associate with early mortality and acute graft-versus-host disease severity in HLA-matched sibling bone marrow transplants. Blood. 1999;94:3941.

    PubMed  CAS  Google Scholar 

  18. Resende R, Correia-Silva J, Arão T, Silva T, Abreu M, Bittencourt H, Gomez R. Investigation of functional IL-10 gene polymorphism and IL-10 levels in acute graft-versus-host disease. J Clin Immunol. 2010;30:465–73.

    Article  PubMed  CAS  Google Scholar 

  19. Azarpira N, Ramzi M, Aghdaie M, Darai M, Geramizadeh B. Interleukin-10 gene polymorphism in bone marrow transplant recipients. Exp Clin Transplant. 2008;6:74.

    PubMed  Google Scholar 

  20. Xiao H, Cao W, Lai X, Luo Y, Shi J, Tan Y, He J, Xie W, Meng X, Zheng W. Immunosuppressive cytokine gene polymorphisms and outcome after related and unrelated hematopoietic cell transplantation in a Chinese population. Biol Blood Marrow Transplant. 2011;17:542–9.

    Article  PubMed  CAS  Google Scholar 

  21. Przepiorka D, Weisdorf D, Martin P, Klingemann H, Beatty P, Hows J, Thomas E. 1994 consensus conference on acute GVHD grading. Bone Marrow Transplant. 1995;15:825.

    PubMed  CAS  Google Scholar 

  22. Higgins J, Thompson S, Deeks J, Altman D. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557.

    Article  PubMed  Google Scholar 

  23. Mullighan C, Heatley S, Doherty K, Szabo F, Grigg A, Hughes T, Schwarer A, Szer J, Tait B, To B. Non-HLA immunogenetic polymorphisms and the risk of complications after allogeneic hemopoietic stem-cell transplantation. Transplantation. 2004;77:587.

    Article  PubMed  CAS  Google Scholar 

  24. Moore K, de Waal-Malefyt R, Coffman R, O’Garra A. Interleukin-10 and the interleukin-10 receptor. Ann Rev Immunol. 2001;19:683–765.

    Article  CAS  Google Scholar 

  25. Taylor P, Lees C, Blazar B. The infusion of ex vivo activated and expanded CD4+CD25+ immune regulatory cells inhibits graft-versus-host disease lethality. Blood. 2002;99:3493.

    Article  PubMed  CAS  Google Scholar 

  26. Hoffmann P, Ermann J, Edinger M, Fathman C, Strober S. Donor-type CD4+CD25+ regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation. J Exp Med. 2002;196:389.

    Article  PubMed  CAS  Google Scholar 

  27. Keijsers V, Verweij C, Westendorp R, Breedveld F, Huizinga T. IL-10 polymorphisms in relation to production and rheumatoid arthritis. Arthritis Rheum. 1997;40:179.

    Article  Google Scholar 

  28. Hempel L, Körholz D, Nussbaum P, Bönig H, Burdach S, Zintl F. High interleukin-10 serum levels are associated with fatal outcome in patients after bone marrow transplantation. Bone Marrow Transplant. 1997;20:365–8.

    Article  PubMed  CAS  Google Scholar 

  29. Takatsuka H, Takemoto Y, Okamoto T, Fujimori Y, Tamura S, Wada H, Okada M, Yamada S, Kanamaru A, Kakishita E. Predicting the severity of graft-versus-host disease from interleukin-10 levels after bone marrow transplantation. Bone Marrow Transplant. 1005;1999:24.

    Google Scholar 

  30. Holler E, Roncarolo M, Hintermeier-Knabe R, Eissner G, Ertl B, Schulz U, Knabe H, Kolb H, Andreesen R, Wilmanns W. Prognostic significance of increased IL-10 production in patients prior to allogeneic bone marrow transplantation. Bone Marrow Transplant. 2000;25:237.

    Article  PubMed  CAS  Google Scholar 

  31. Dickinson A, Middleton P, Rocha V, Gluckman E, Holler E. Genetic polymorphisms predicting the outcome of bone marrow transplants. Br J Haematol. 2004;127:479–90.

    Article  PubMed  CAS  Google Scholar 

  32. Helminen M, Kilpinen S, Virta M, Hurme M. Susceptibility to primary Epstein-Barr virus infection is associated with interleukin-10 gene promoter polymorphism. J Infect Dis. 2001;184:777–81.

    Article  PubMed  CAS  Google Scholar 

  33. Temple S, Lim E, Cheong K, Almeida C, Price P, Ardlie K, Waterer G. Alleles carried at positions −819 and −592 of the IL10 promoter affect transcription following stimulation of peripheral blood cells with Streptococcus pneumoniae. Immunogenetics. 2003;55:629–32.

    Article  PubMed  CAS  Google Scholar 

  34. Kingo K, Rätsep R, Kõks S, Karelson M, Silm H, Vasar E. Influence of genetic polymorphisms on interleukin-10 mRNA expression and psoriasis susceptibility. J Dermatol Sci. 2005;37:111–3.

    Article  PubMed  CAS  Google Scholar 

  35. Gibson AW, Edberg JC, Wu J, Westendorp RGJ, Huizinga TWJ, Kimberly RP. Novel single nucleotide polymorphisms in the distal IL-10 promoter affect IL-10 production and enhance the risk of systemic lupus erythematosus. J Immunol. 2001;166:3915.

    PubMed  CAS  Google Scholar 

  36. Hoffmann SC, Stanley EM, Cox ED, DiMercurio BS, Koziol DE, Harlan DM, Kirk AD, Blair PJ. Ethnicity greatly influences cytokine gene polymorphism distribution. Am J Transplant. 2002;2:560–7.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

The National Natural Science Foundation of China (Grant No. 81072440), NSFC-Guangdong Union Grant (Grant No. U0832003) and Hubei Province Natural Science Fund project (2012FFB03708) supported this work.

Conflict of interest

The authors declare no financial conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Li Xie.

Electronic supplementary material

Below is the link to the electronic supplementary material.

12185_2013_1363_MOESM1_ESM.tif

Fig.S1. Flow chart of article selection for meta-analysis. IU = HLA-identical unrelated; IS = HLA-identical sibling; aGVHD = acute graft-versus-host disease; R = recipient; D = donor; n = number of eligible studies (TIFF 1033 kb)

Supplementary material 2 (DOC 125 kb)

About this article

Cite this article

Zhu, P., Xie, L., Yang, Y. et al. IL-10 promoter polymorphism associated with decreased risk of aGvHD after stem cell transplantation: a meta-analysis. Int J Hematol 98, 102–111 (2013). https://doi.org/10.1007/s12185-013-1363-3

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12185-013-1363-3

Keywords

Navigation